Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Neoplasms × Radiotherapy, Adjuvant × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 5 Esophageal Neoplasms 3 Prostatic Neoplasms 2 Phyllodes Tumor 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma 1 Postoperative Complications 1 Oropharyngeal Neoplasms 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Mouth Neoplasms 1 Lymphatic Metastasis 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Surveys and Questionnaires 98 Exercise 88 Blood Specimen Collection 86 Radiotherapy 60 Gemcitabine 53 Bevacizumab 52 Cisplatin 50 Standard of Care 49 Capecitabine 47 Dexamethasone 44 Cyclophosphamide 44 Carboplatin 44 Docetaxel 41 Paclitaxel 40 Interviews as Topic 40 pembrolizumab 39 Oxaliplatin 38 Methods 35 Irinotecan 35 Fluorouracil 35 Magnetic Resonance Spectroscopy 33 Therapeutics 29 Radiosurgery 28 Nivolumab 27 Drug Therapy 26 Educational Status 25 Leucovorin 22 Everolimus 21 Control Groups 21 Cognitive Behavioral Therapy 20

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00860652 2022-11-18

RAVES

Trans Tasman Radiation Oncology Group

Phase NA Active not recruiting

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡